临床研究阶段
参考资料

1 2 3 4 5 6 7 8  . US Food and Drug Administration. 4 January 2018  [17 August 2020]. （原始内容存档于2020-02-22）.
↑  Amanna, Ian J.; Slifka, Mark K. .  428. Springer International Publishing. 2018: 1–30. ISBN 978-3-030-58003-2. ISSN 0070-217X. PMC 6777997 . PMID 34129355. doi:10.1007/82_2018_102. eISSN 2196-9965. The effect of vaccines on public health is truly remarkable. One study examining the impact of childhood vaccination on the 2001 US birth cohort found that vaccines prevented 33,000 deaths and 14 million cases of disease (Zhou et al. 2005). Among 73 nations supported by the GAVI alliance, mathematical models project that vaccines will prevent 23.3 million deaths from 2011–2020 compared to what would have occurred if there were no vaccines available (Lee et al. 2013). Vaccines have been developed against a wide assortment of human pathogens.
↑  . U.S. Food & Drug Administration. 2018-11-03  [16 March 2019]. （原始内容存档于2019-04-23）.
↑   (PDF). Who-umc.org.   [2015-02-27]. （原始内容存档 (PDF)于2022-10-11）.
↑  . Research Administration, University of California, Irvine.   [2012-01-04]. （原始内容存档于2013-04-20）.
↑  WHO. . www.who.int. WHO.   [2023-06-24]. （原始内容存档于2023-10-07）.
↑  WHO.  (PDF)使用|format=需要含有|url= (帮助). Switzerland: WHO. 2018: 6. ISBN 978-92-4-151474-3 （英语）.  使用|accessdate=需要含有|url= (帮助)
↑  . BIO, Informa Pharma Intelligence, and QLS Advisors. Feb 2021  [2023-06-19]. （原始内容存档于2023-02-08）.
↑  . echa.europa.eu.   [2023-04-11]. （原始内容存档于2023-03-29） （英国英语）.
↑  Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P,  et al. . Biotechnology Advances. December 2015, 33 (8): 1582–1614. PMC 4748402 . PMID 26281720. doi:10.1016/j.biotechadv.2015.08.001.
↑  Skloot R. . Random House. 2010  [2020-09-20]. ISBN 978-0-307-71253-0. OCLC 974000732. （原始内容存档于2024-02-22）.
↑  Shargel, L.; Yu, A.B.  4th ed. New York: McGraw-Hill. 1999. ISBN 978-0-8385-0278-5.  引文格式1维护：冗余文本 (link)
↑  Britannica, The Editors of Encyclopaedia. . .   [2023-06-21]. （原始内容存档于2023-02-24）.
↑  Ting, Naitee. . Springer-Verlag. 2006. ISBN 0-387-29074-5.
1 2  McNeil JJ, Piccenna L, Ronaldson K,  et al. . Pharm Med. 2010, 24 (5): 281–288  [2011-06-17]. S2CID 19091146. doi:10.1007/bf03256826. （原始内容存档于2012-07-07）.
↑  Patrick, Graham L. . 2009-03: 62. ISBN 9780199234479.
↑  .   [2021-07-27]. （原始内容存档于2021-08-04）.
↑  Dixit, Vaibhav. . Toxicology Research. 2019, 8 (2): 157–171. PMC 6417485 . PMID 30997019. doi:10.1039/C8TX00261D.
↑  Gabrielsson J, Weiner D (2006) Pharmacokinetic and pharmacodynamic data analysis: concepts and applications, 4th edn. Swedish Pharmaceutical Press, Stockholm
↑  CDER.  (PDF). Guidance for Industry, Investigators, and Reviewers. Food and Drug Administration. January 2006  [2010-06-15]. （原始内容存档 (PDF)于2009-07-09）.
↑  The Lancet. . Lancet. July 2009, 374 (9685): 176. PMID 19616703. S2CID 30939770. doi:10.1016/S0140-6736(09)61309-X .
↑  Burt, Tal; Young, Graeme; Lee, Wooin; Kusuhara, Hiroyuki; Langer, Oliver; Rowland, Malcolm; Sugiyama, Yuichi. . Nature Reviews Drug Discovery. 2020, 19 (11): 801–818. ISSN 1474-1784. PMID 32901140. doi:10.1038/s41573-020-0080-x  （英语）.
↑  Fisher JA. . Science, Technology, & Human Values. March 2015, 40 (2): 199–226. PMC 4405793 . PMID 25914430. doi:10.1177/0162243914554838.
1 2 3 4 5 6 7  . American Cancer Society. 18 August 2020  [15 September 2020]. （原始内容存档于2020-10-05）.
↑  . National Cancer Institute. 2011-02-02  [2023-06-19]. （原始内容存档于2020-04-13）.
↑  Van den Eynde BJ, van Baren N, Baurain JF. . Annual Review of Cancer Biology. 2020, 4: 241–256. doi:10.1146/annurev-cancerbio-030419-033635 .
1 2  . US Food and Drug Administration. 14 October 2016  [1 February 2017]. （原始内容存档于2019-03-28）.
↑  Lees P, Cunningham FM, Elliott J. . J. Vet. Pharmacol. Ther. 2004, 27 (6): 397–414. PMID 15601436. doi:10.1111/j.1365-2885.2004.00620.x.
↑  Shamoo AE. . Medscape Journal of Medicine. 2008, 10 (11): 254  [2023-06-19]. PMC 2605120 . PMID 19099004. （原始内容存档于2019-11-04）.
1 2 3 4 5 6 7 8 9  DeMets D, Friedman L, Furberg C.  4th. Springer. 2010. ISBN 978-1-4419-1585-6.
1 2  Norfleet, Elizabeth; Gad, Shayne Cox. . 2009: 247. ISBN 978-0-470-46635-3.
↑  Muller PY, Milton MN. . Nature Reviews. Drug Discovery. October 2012, 11 (10): 751–61. PMID 22935759. doi:10.1038/nrd3801.
↑  Trevor A, Katzung B, Masters S, Knuidering-Hall M. .  10th. New York: McGraw-Hill Medical. 2013: 17  [2017-05-05]. ISBN 978-0-07-178923-3. （原始内容存档于2017-01-16）.
↑  Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI.  (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707  [2023-05-02]. PMID 16846797. doi:10.1016/j.drudis.2006.06.013. （原始内容 (pre-print)存档于2013-09-12）.
↑  Jianyuan Deng, Jianyuan; Zhu, Xiao; Chen, Zongmeng; Fan, Chun Ho; Kwan, Him Shek; Wong, Chi Ho; Shek, Ka Yi; Zuo, Zhong; Lam, Tai Ning; Xiao Zhu, Zongmeng Chen, Chun Ho Fan, Him Shek Kwan, Chi Ho Wong, Ka Yi Shek, Zhong Zuo & Tai Ning Lam. . Drugs. 2017-11, 77 (17): 1833–1855  [2023-06-25]. ISSN 1179-1950. doi:10.1007/s40265-017-0832-z. （原始内容存档于2023-06-25）.  引文使用过时参数coauthors (帮助)
↑  . September 2020  [2023-06-21]. （原始内容存档于2017-12-25）.
↑  . National Human Genome Research Institute (NHGRI).   [2017-11-08]. （原始内容存档于2017-12-01） （美国英语）.
1 2  Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P. . Journal of Biopharmaceutical Statistics. 2016, 26 (5): 912–23. PMC 5025390 . PMID 26390951. doi:10.1080/10543406.2015.1094807.
1 2  Richard Pazdur, R. . Journal of the National Cancer Institute. 2000-10-04, 92 (19): 1552–1553  [2023-06-25]. （原始内容存档于2023-06-25）.
↑  . www.dictionary.com.   [2023-06-25]. （原始内容存档于2023-03-29）.
↑  EMA.  (PDF). www.ema.europa.eu. EMA.   [2023-06-25]. （原始内容存档 (PDF)于2023-06-01）.
↑  . MedCity News. 2011-06-02  [2023-06-19]. （原始内容存档于2024-03-05）.
↑   (PDF). bio.org.   [2018-02-11]. （原始内容存档 (PDF)于2019-09-12）.
↑  . Food and Drug Administration (United States)|Food and Drug Administration. 1999-03-16  [2007-03-27]. （原始内容存档于2001-05-06）.
↑  FDA. . www.fda.gov.   [2023-06-25]. （原始内容存档于2023-06-25）.
↑  The regulatory authority in the US is the Food and Drug Administration; in Canada, Health Canada; in the European Union, the European Medicines Agency; and in Japan, the Ministry of Health, Labour and Welfare
↑  Arcangelo VP, Peterson AM. . Lippincott Williams & Wilkins. 2005. ISBN 978-0-7817-5784-3.  含有內容需登入查看的頁面 (link)
↑  Van Norman GA. . JACC. Basic to Translational Science. June 2019, 4 (3): 428–437. PMC 6609997 . PMID 31312766. doi:10.1016/j.jacbts.2019.02.005.
↑   (PDF). U.S. Food and Drug Administration. 1 November 2019  [3 April 2020]. （原始内容存档于2019-12-13）.
1 2  Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV,  et al. . BMC Medicine. February 2018, 16 (1): 29. PMC 5830330 . PMID 29490655. doi:10.1186/s12916-018-1017-7.
↑  . www.isrctn.com.   [2023-06-21]. （原始内容存档于2020-08-26）.
↑  . United Nations, World Health Organization. 18 March 2020  [2 April 2020]. （原始内容存档于2020-03-23） （英语）.
↑  Kupferschmidt, Kai; Cohen, Jon. . Science (AAAS). 22 March 2020  [2 April 2020]. （原始内容存档于2020-09-14） （英语）.
↑  Kotok, Alan. . Technology News: Science and Enterprise. 19 March 2020  [7 April 2020]. （原始内容存档于2020-08-09）.
↑  . INSERM. 22 March 2020  [5 April 2020]. （原始内容存档于2020-10-08）. The great strength of this trial is its "adaptive" nature. This means that ineffective experimental treatments can very quickly be dropped and replaced by other molecules that emerge from research efforts. We will therefore be able to make changes in real time, in line with the most recent scientific data, in order to find the best treatment for our patients
↑  .   [17 June 2020]. （原始内容存档于2020-10-12）.
↑  Lo A, Siah K, Wong C. . Harvard Data Science Review (MIT Press). 14 May 2020, (Special Issue 1 - COVID-19)  [11 August 2020]. doi:10.1162/99608f92.e0c150e8 . （原始内容存档于2020-08-11）. we can see that the overall probability of success (PoS) for industry-sponsored vaccine development programs is 39.6%... In contrast, non-industry-sponsored vaccine development programs have an overall PoS of only 6.8%
1 2 3  Wong, Chi Heem; Siah, Kien Wei; Lo, Andrew W. . Biostatistics. 2018-01-31, 20 (2): 273–286  [2023-06-19]. ISSN 1465-4644. PMC 6409418 . PMID 29394327. S2CID 3277297. doi:10.1093/biostatistics/kxx069 . （原始内容存档于2023-06-19）.
↑  Hirsch MS, Watkins J. . Advances in Anatomic Pathology. May 2020, 27 (3): 164–192. PMID 31149908. S2CID 171094630. doi:10.1097/PAP.0000000000000238.
↑  Arrowsmith J. . Nature Reviews. Drug Discovery. February 2011, 10 (2): 87. PMID 21283095. S2CID 39480483. doi:10.1038/nrd3375.
↑  Sertkaya A, Wong HH, Jessup A, Beleche T. . Clinical Trials. April 2016, 13 (2): 117–26. PMID 26908540. S2CID 24308679. doi:10.1177/1740774515625964.
↑   (报告). World Health Organization. 2002  [31 December 2020]. ISBN 9241590157. （原始内容存档于2023-04-09）.
↑  Tannenbaum C, Sheehan NL. . Expert Review of Clinical Pharmacology. July 2014, 7 (4): 533–44. PMC 4894065 . PMID 24745854. doi:10.1586/17512433.2014.910111.
↑  .   [2023-06-21]. （原始内容存档于2019-08-20）.
↑  Fisher, Lawrence. . The New York Times. 4 November 1997  [12 December 2012]. （原始内容存档于2023-06-21）.
↑   (PDF). FDA.   [2023-06-21]. （原始内容存档 (PDF)于2013-08-22）.
↑  Holland J. . Journal of Commercial Biotechnology. 2013, 19. doi:10.5912/jcb588.
↑  Adams CP, Brantner VV. . Health Affairs. 2006, 25 (2): 420–8. PMID 16522582. doi:10.1377/hlthaff.25.2.420 .